SCHEMBL89927

SCHEMBL89927

CCOC[C@@H](CC(C)C)NC(=O)[C@H]1C[C@@H](C(=O)N(c2cc(OCCCOC)c(C(C)C)cc2F)C2CC2)CN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.75
KCNH2 Q12809 5/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL90289 0.94 REN (0.65) RENKCNH2
SCHEMBL89882 0.94 REN (0.64) RENKCNH2
SCHEMBL90282 0.93 REN (0.64) RENKCNH2
SCHEMBL89385 0.89 REN (0.74) RENKCNH2
SCHEMBL1911413 0.89 REN (0.74) RENKCNH2
SCHEMBL90716 0.87 REN (0.55) RENKCNH2
SCHEMBL89844 0.86 REN (0.55) RENKCNH2
SCHEMBL8235848 0.86 REN (0.54) RENKCNH2
SCHEMBL90342 0.86 REN (1.00) RENKCNH2
SCHEMBL89890 0.85 REN (0.53) RENKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129411-B2 Organic compounds NOVARTIS AG (CH) 2012-03-06 US disclosed
US-20090192148-A1 Organic Compounds NOVARTIS AG (CH) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192148-A1 Organic Compounds REN, ACE, AGTR1 REN 1/4885KCNH2 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.